Unassociated Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

  FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 10, 2011

Chemtura Corporation
(Exact name of registrant as specified in its charter)


Delaware
(State or other jurisdiction
 of incorporation)
  
1-15339
(Commission file number)
  
52-2183153
(IRS employer identification
            number)
 
1818 Market Street, Suite 3700, Philadelphia, Pennsylvania
199 Benson Road, Middlebury, Connecticut
   (Address of principal executive offices)
      
19103
06749
 (Zip Code)

(203) 573-2000
(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 

Item 5.07.  Submission of Matters to a Vote of Security Holders.

On May 10, 2011, Chemtura Corporation held its 2011 Annual Meeting of Shareholders.  The matters listed below were submitted to a vote of the shareholders through the solicitation of proxies, and the proposals are described in detail in Chemtura’s Proxy Statement filed with the Securities and Exchange Commission on April 4, 2011 (the “Proxy Statement”).  The results of the shareholder vote are as follows:

a.  
Messrs. Jeffrey D. Benjamin, Timothy J. Bernlohr, Alan S. Cooper, James W. Crownover, Jonathan F. Foster, Craig A. Rogerson, John K. Wulff and Ms. Anna C. Catalano were each elected by the shareholders to a term to expire in 2012 or until their respective successors are duly elected and qualified.

Nominees
  
For
  
Withheld
  
Broker Non-Votes
Jeffrey D. Benjamin
  
63,267,171
  
  270,477
  
  15,170,354
Timothy J. Bernlohr
  
63,042,569
  
  495,079
  
  15,170,354
Anna C. Catalano
  
63,266,566
  
  271,082
  
  15,170,354
Alan S. Cooper
  
63,269,541
  
  268,107
  
  15,170,354
James W. Crownover
  
63,264,313
  
  273,335
  
  15,170,354
Jonathan F. Foster
  
63,267,428
  
  270,220
  
  15,170,354
Craig A. Rogerson
  
61,670,482
  
1,867,166
  
  15,170,354
John K. Wulff
  
54,665,630
  
8,872,018
  
  15,170,354

b.  
The shareholders approved, on an advisory (non-binding) basis, the compensation paid to Chemtura’s named executive officers disclosed in the Proxy Statement, including the Compensation Discussion and Analysis, the compensation tables and related disclosures.

For
  
Against
  
Abstain
  
Broker Non-Votes
62,038,570
  
620,401
  
878,677
  
15,170,354

c.  
The shareholders voted, on an advisory (non-binding) basis, the frequency of which Chemtura should hold advisory votes on executive compensation.

1 Year
  
2 Years
  
3 Years
  
Abstain
  
Broker Non-Votes
58,422,717
  
57,601
  
4,142,565
  
914,765
  
15,170,354

Consistent with a majority of the votes cast with respect to this proposal and with the recommendation of Chemtura’s Board of Directors, Chemtura will hold a shareholder advisory vote on the compensation of Chemtura’s named executive officers annually until the next required vote on the frequency of shareholder votes on the compensation of Chemtura’s named executive officers as required pursuant to Section 14(A) of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.

d.  
The shareholders ratified the appointment of KPMG LLP as Chemtura’s independent registered public accounting firm for 2011.
 
For
  
Against
  
Abstain
78,544,877
  
138,786
  
18,977


 
 
 
 
Signatures

            Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Chemtura Corporation
  
    (Registrant)  
       
 
By:
/s/ Billie S. Flaherty  
 
Name:  
Billie S. Flaherty  
 
Title:
SVP, General Counsel & Secretary
  
 
Date:
May 12, 2011